PBTK modeling of potential endocrine modulators: In vitro-in vivo extrapolation (IVIVE) and in silico-in vitro based risk assessments

被引：0
|
作者：
Fabian, E. [1 ]
Haase, C. [1 ]
Ramirez, T. [1 ]
Gomes, C. [1 ]
Birk, B. [1 ]
van Ravenzwaay, B. [1 ]
Landsiedel, R. [1 ]
机构：
[1] BASF SE, Expt Toxicol & Ecol, Ludwigshafen, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2017年 / 390卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P265
引用
收藏
页码：S79 / S79
页数：1
相关论文
共 50 条
  • [1] PBTK modeling of selected potential endocrine modulators: In vitro-in vivo extrapolation (IVIVE) and in silico/in vitro based risk assessments
    Haase, C.
    Fabian, E.
    Ramirez, T.
    van Ravenzwaay, B.
    Landsiedel, R.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 389 (01) : S47 - S47
  • [2] Transporter-based in vitro-in vivo extrapolation (IVIVE)
    Lukacova, Viera
    Bolger, Michael B.
    Woltosz, Walter
    Parrott, Neil
    Poirier, Agnes
    Lave, Thierry
    DRUG METABOLISM REVIEWS, 2011, 43 : 210 - 211
  • [3] Importance of in vitro conditions for modeling the in vivo dose in humans by in vitro-in vivo extrapolation (IVIVE)
    Algharably, Engi Abdel Hady
    Kreutz, Reinhold
    Gundert-Remy, Ursula
    ARCHIVES OF TOXICOLOGY, 2019, 93 (03) : 615 - 621
  • [4] In vitro-to-in vivo extrapolation (IVIVE) by PBTK modeling for animal-free risk assessment approaches of potential endocrine-disrupting compounds
    Fabian, Eric
    Gomes, Caroline
    Birk, Barbara
    Williford, Tabitha
    Hernandez, Tzutzuy Ramirez
    Haase, Christian
    Zbranek, Rene
    van Ravenzwaay, Bennard
    Landsiedel, Robert
    ARCHIVES OF TOXICOLOGY, 2019, 93 (02) : 401 - 416
  • [5] In vitro-to-in vivo extrapolation (IVIVE) by PBTK modeling for animal-free risk assessment approaches of potential endocrine-disrupting compounds
    Eric Fabian
    Caroline Gomes
    Barbara Birk
    Tabitha Williford
    Tzutzuy Ramirez Hernandez
    Christian Haase
    Rene Zbranek
    Bennard van Ravenzwaay
    Robert Landsiedel
    Archives of Toxicology, 2019, 93 : 401 - 416
  • [6] Refinement of in vitro to in vivo extrapolation (IVIVE) of potential endocrine disruptors based on in vitro dosimetry approaches
    Dimitrijevic, D.
    Fabian, E.
    Gomes, C.
    Funk-Weyer, D.
    Landsiedel, R.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2022, 395 (SUPPL 1) : S67 - S67
  • [7] Using physiologically based pharmacokinetic modelling for in silico-in vitro-in vivo extrapolation to predict chemical exposure
    Lawless, M.
    Zhou, H.
    Fraczkiewicz, G.
    TOXICOLOGY LETTERS, 2016, 258 : S119 - S120
  • [8] Predictive performance of physiologically based kinetic (PBK) models based on in-silico/in vitro-in vivo extrapolation (IS/IVIVE)
    Kalra, P.
    Zhou, H.
    Lawless, M.
    TOXICOLOGY LETTERS, 2023, 384 : S259 - S260
  • [9] Predictive performance of physiologically based kinetic (PBK) models based on in-silico/in vitro-in vivo extrapolation (IS/IVIVE)
    Kalra, P.
    Zhou, H.
    Lawless, M.
    TOXICOLOGY LETTERS, 2024, 399 : S125 - S126
  • [10] PBPK Modeling and In Vitro to In Vivo Extrapolation (IVIVE) Modeling.
    Bell, S.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2021, 62 : 30 - 30
12345